Jean M. Franchi

Biography

Ms. Franchi spent more than 20 years building and leading senior corporate and divisional financial teams from the research and development stage through product launch and commercial operations in the public and private pharmaceutical, biotech, and diagnostics sectors. Ms. Franchi joins the board of directors having experience as Chief Financial Officer at Dimension Therapeutics and Good Start Genetics. Currently CFO at Merrimack, a biotechnology company specializing in oncology and listed on the Nasdaq, Previously, Ms. Franchi spent 16 years at Genzyme Corporation, where she held roles of increasing responsibility and was instrumental in preparing the company for its transition from early market introductions to becoming the industry leader in rare disease drug development and commercialization. Earlier in her career, Ms. Franchi worked in accounting, finance, and sales operations for two diagnostic companies: bioMérieux, Inc., and API, a former division of American Home Products (now Pfizer). Ms. Franchi received her B.A. degree in Business Administration from Hofstra University.

Research Interest

biotechnology